Phosphodiesterase Inhibitors

All categories
DBCAT000509Therapeutic categoryC01CE

Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. A DrugBank category of 56 drugs. 25 of them are approved.

ATC classification
Also known as
Antiphosphodiesterases · Phosphodiesterase (PDE) inhibitors · Phosphodiesterase Antagonists · Phosphoric Diester Hydrolase Inhibitors
Drugs

and 31 more with a free account

What you can answer from here — as of September 02, 2021

56DrugsEach linked to its full drug card
Sign in
64Drug targetsEvery drug–target pair in the class, with bond type
Sign in
7,649Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
14Routes of administrationHow the drugs in this class are given
Sign in
2SubcategoriesNarrower classes within this one
Sign in

Which targets do Phosphodiesterase Inhibitors share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In